Auf dieser Seite
KRRO Korro Bio, Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 6, 2026
$9,64
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$5,2052-Wochen-Tief
$55,8952-Wochen-Hoch
Marktkapitalisierung (MRQ)
$142M
P/E (TTM)
-1.0
EPS (TTM)
$-10.01
Umsatz (TTM)
$2M
Ihre Abzeichen
52W-Spanne
$5–$56
Analystenbewertung
BUY
Kursziel
$20
P/E
-1.0
ROE
-97.7%
Nettogewinnmarge
-4477.1%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
KRRO Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$9.64
Marktkapitalisierung (MRQ)
$142M
P/E (TTM)
-1.0
EPS (TTM)
$-10.01
Umsatz (TTM)
$2M
ROE (TTM)
-97.7%
52W-Spanne
$5–$56
KRRO Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 6. November 2023 | 1-for-50 | Umgekehrt |
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$6M2019-12-31 → 2025-12-31
EPS$-12.482022-12-31 → 2025-12-31
Freier Cashflow$-79M2019-12-31 → 2025-12-31
Nettogewinnmarge-4477.1%2019-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | KRRO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -1.05-Jahres-Durchschnitt ≈-1.6 | ≈-1.6 | · | · | |
| P/S (TTM) | 59.55-Jahres-Durchschnitt ≈266.7 | ≈266.7 | 29.5 | Überbewertet | |
| K/B (MRQ) | 1.45-Jahres-Durchschnitt ≈18.5 | ≈18.5 | 1.9 | Fairer Wert | |
| Kurs / FCF (TTM) | -2.15-Jahres-Durchschnitt ≈-30.8 | ≈-30.8 | · | · | |
| Kurs / Cashflow (TTM) | -2.15-Jahres-Durchschnitt ≈-32.3 | ≈-32.3 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 2.75-Jahres-Durchschnitt ≈2.0 | ≈2.0 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | KRRO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -4625.5%5-Jahres-Durchschnitt ≈-2183.6% | ≈-2183.6% | -1906.4% | Im Einklang | |
| EBITDA Margin (EBITDA-Marge) | -1906.4%5-Jahres-Durchschnitt ≈-2183.6% | ≈-2183.6% | -1906.4% | Im Einklang | |
| Vorgewinnmarge (TTM) | -4441.9%5-Jahres-Durchschnitt ≈-2033.5% | ≈-2033.5% | -3650.4% | Spitzenklasse | |
| Nettogewinnmarge (TTM) | -4477.1%5-Jahres-Durchschnitt ≈-2038.9% | ≈-2038.9% | -1834.5% | Im Einklang | |
| ROA (TTM) | -62.0%5-Jahres-Durchschnitt ≈-49.7% | ≈-49.7% | -69.0% | Im Einklang | |
| ROE (TTM) | -97.7%5-Jahres-Durchschnitt ≈-306.4% | ≈-306.4% | -81.2% | Schwach | |
| ROIC | -238.2%5-Jahres-Durchschnitt ≈-102.3% | ≈-102.3% | -75.7% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | KRRO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 9.65-Jahres-Durchschnitt ≈9.1 | ≈9.1 | 6.5 | Starke Liquidität | |
| Quick Ratio | 6.35-Jahres-Durchschnitt ≈7.6 | ≈7.6 | 4.1 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | KRRO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 181.5% | · | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | -45.6% | · | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | -29.6% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | KRRO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.05-Jahres-Durchschnitt ≈0.0 | ≈0.0 | 0.0 | Spitzenklasse | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$112.1K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
14.7%
Nächster Bericht
Nov 10, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 18, 2026 | $-1.07 | $-1.48 | 27.7% |
| 31. März 2026 | Mai 19, 2026 | $-1.69 | $-1.88 | 10.0% |
| 31. Dezember 2025 | $-1.65 | $-2.11 | 21.7% | |
| 30. September 2025 | $-1.92 | $-2.65 | 27.4% | |
| 30. Juni 2025 | $-2.74 | $-2.62 | -4.8% | |
| 31. März 2025 | $-2.49 | $-2.66 | 6.2% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6M | $2M | $0 | $0 | $14M | $37M | $29M | |
| R&D Expense | $66M | $64M | $57M | $42M | $61M | $37M | $19M | |
| SG&A Expense | $28M | $31M | $27M | $17M | $37M | $27M | $15M | |
| Operating Expenses | $128M | $94M | $85M | $59M | $98M | $65M | $50M | |
| Operating Income | $-122M | $-92M | $-85M | $-59M | $-84M | $-28M | $-21M | |
| Interest Expense | · | · | · | $961.0K | $764.0K | $0 | · | |
| Interest Income | · | · | · | $1M | $397.0K | $994.0K | $2M | |
| Other Non-op | $5M | $8M | $3M | $976.0K | $-266.0K | · | · | |
| Pretax Income | $-117M | $-83M | $-81M | $-58M | $-85M | $-26M | $-19M | |
| Income Tax | $637.0K | $141.0K | $27.0K | $10.0K | $15.0K | $35.0K | $0 | |
| Net Income | $-117M | $-84M | $-81M | $-58M | $-85M | $-27M | $-19M | |
| EPS (Basic) | $-12.48 | $-9.37 | $-53.08 | $-227.42 | · | · | · | |
| EPS (Diluted) | $-12.48 | $-9.37 | $-53.08 | $-227.42 | · | · | · | |
| Shares (Basic) | 9,395,402 | 8,920,561 | 1,529,321 | 255,175 | · | · | · | |
| Shares (Diluted) | 9,395,402 | 8,920,561 | 1,529,321 | 255,175 | · | · | · | |
| EBITDA | $-122M | $-92M | $-85M | · | $-84M | $-28M | $-21M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $22M | $56M | $166M | $36M | $80M | $220M | $200M | |
| Short-term Investments | $53M | $70M | $0 | $19M | · | · | · | |
| Prepaid Expense | $6M | $4M | $3M | $1M | $4M | $5M | $4M | |
| Other Current Assets | · | · | · | $255.0K | $185.0K | $102.0K | $199.0K | |
| Current Assets | $82M | $132M | $173M | $57M | $135M | $225M | $221M | |
| PP&E (Net) | $8M | $28M | $16M | $10M | $6M | $7M | $2M | |
| PP&E (Gross) | $19M | $35M | $24M | $14M | $10M | $10M | $4M | |
| Accum. Depreciation | $11M | $7M | $8M | $4M | $4M | $3M | $2M | |
| Other Non-current Assets | $2M | $3M | $3M | $228.0K | · | · | $101.0K | |
| Total Assets | $114M | $226M | $222M | $74M | $185M | $265M | $223M | |
| Accounts Payable | $2M | $4M | $7M | $3M | $3M | $6M | $1M | |
| Accrued Liabilities | $8M | $6M | $10M | $3M | $6M | $7M | $3M | |
| Current Liabilities | $12M | $15M | $19M | $9M | $11M | $27M | $53M | |
| Capital Leases | $41M | $43M | $31M | $209.0K | $29M | $31M | · | |
| Other Non-current Liabilities | $1M | $1M | $1M | $0 | $87.0K | · | · | |
| Total Liabilities | $62M | $66M | $52M | $9M | $55M | $72M | $56M | |
| Total Debt | · | · | · | · | $833.0K | · | $180.0K | |
| Common Stock | $9.0K | $9.0K | $8.0K | $0 | $35.0K | $34.0K | $31.0K | |
| Paid-in Capital | $435M | $427M | $353M | $3M | $311M | $288M | $236M | |
| Retained Earnings | $-384M | $-267M | $-183M | $-102M | $-180M | $-95M | $-69M | |
| AOCI | $212.0K | $268.0K | $0 | $-5.0K | $-62.0K | $27.0K | $54.0K | |
| Stockholders' Equity | $51M | $160M | $170M | $-99M | $-42M | $192M | $167M | |
| Liabilities + Equity | $114M | $226M | $222M | $74M | $185M | $265M | $223M | |
| Shares Outstanding | 9,417,295 | 9,377,259 | 8,016,516 | 268,399 | 237,803 | 33,964,000 | 30,844,507 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | · | · | · | $20M | $22M | $10M | $4M | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Restructuring | $4M | $0 | · | · | · | · | · | |
| Operating Cash Flow | $-79M | $-60M | $-67M | $-54M | $-76M | $-45M | $34M | |
| CapEx | $518.0K | $18M | $8M | $5M | $3M | $7M | $1M | |
| Investing Cash Flow | $44M | $-123M | $11M | $11M | $-66M | $10M | $-18M | |
| Debt Issued | · | · | · | · | · | $15M | · | |
| Net Debt Issued | · | · | · | · | · | $15M | · | |
| Stock Issued | · | $0 | $117M | $0 | $1M | $2M | $80M | |
| Net Stock Activity | · | $0 | $117M | · | $1M | $2M | $80M | |
| Financing Cash Flow | $685.0K | $69M | $188M | $18.0K | $1M | $57M | $142M | |
| Net Change in Cash | $-34M | $-114M | $132M | $-43M | $-141M | $22M | $158M | |
| Taxes Paid | $1.0K | $141.0K | $27.0K | $11.0K | · | · | $94.0K | |
| Free Cash Flow | $-79M | $-78M | $-75M | · | $-79M | $-52M | $33M | |
| Levered FCF | · | · | · | · | $-80M | · | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1906.4% | -4047.1% | · | · | -597.3% | -74.5% | -71.4% | |
| Net Margin | -1834.5% | -3680.4% | · | · | -602.0% | -71.7% | -64.8% | |
| Pretax Margin | -1824.5% | -3674.2% | · | · | -601.9% | -71.6% | · | |
| EBITDA Margin | -1906.4% | -4047.1% | · | · | -597.3% | -74.5% | -71.4% | |
| ROA | -69.0% | -37.3% | -55.0% | · | -37.6% | -10.9% | -14.0% | |
| ROE | -140.8% | -49.2% | -974.8% | · | -60.9% | -13.5% | -34.8% | |
| ROIC | -238.2% | -57.4% | -49.8% | · | -63.8% | -14.3% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.9 | 8.8 | 8.9 | · | 11.8 | 8.5 | 4.2 | |
| Quick Ratio | 6.3 | 8.4 | 8.5 | · | 7.0 | 8.3 | 3.8 | |
| Debt / Equity | · | · | · | · | 0.0 | · | 0.0 | |
| LT Debt / Equity | · | · | · | · | · | · | 0.0 | |
| Interest Coverage | · | · | · | · | -110.0 | · | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.2 | 0.2 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.46 | $17.11 | $21.20 | · | $3.78 | $5.67 | $5.43 | |
| Revenue / Share | $0.68 | $0.25 | $0.00 | · | · | · | · | |
| Cash Flow / Share | $-8.36 | $-6.73 | $-44.00 | · | · | · | · | |
| Cash / Share | $2.32 | $5.93 | $20.73 | · | $2.30 | $6.49 | $6.49 | |
| EPS (TTM) | $-12.48 | $-9.37 | $-53.08 | $-227.42 | · | · | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 181.5% | · | · | · | -62.0% | · | · | |
| Revenue CAGR 3Y | · | -45.6% | · | · | · | · | · | |
| Revenue CAGR 5Y | -29.6% | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6M | $2M | $0 | $0 | $14M | $37M | $29M | |
| Net Income TTM | $-117M | $-84M | $-81M | $-58M | $-85M | $-27M | $-19M | |
| Market Cap | $75M | $357M | $384M | · | $8.88B | $59.88B | $27.04B | |
| Enterprise Value | · | · | · | · | $8.80B | · | $26.84B | |
| P/E | -0.6 | -4.1 | -0.9 | -0.8 | · | · | · | |
| P/S | 11.8 | 157.2 | · | · | 631.1 | 1619.0 | 934.0 | |
| P/B | 1.5 | 2.2 | 2.3 | · | 67.9 | 311.1 | 161.5 | |
| P / Tangible Book | 1.5 | 2.2 | 2.3 | · | · | 311.1 | · | |
| P / Cash Flow | -1.0 | -5.9 | -5.7 | · | -116.7 | -1325.1 | 790.2 | |
| P / FCF | -1.0 | -4.6 | -5.1 | · | -112.4 | -1154.6 | 815.5 | |
| EV / EBITDA | · | · | · | · | -104.7 | · | -1298.0 | |
| EV / FCF | · | · | · | · | -111.4 | · | 809.5 | |
| EV / Revenue | · | · | · | · | 625.5 | · | 927.0 | |
| Earnings Yield | -155.8% | -24.6% | -110.7% | -118.1% | · | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $1M | $1M | $1M | $3M | $2M | $0 | $0 | $0 | · | · | · | · | · | $0 | |
| R&D Expense | $14M | $13M | $11M | $14M | $20M | $20M | $17M | $16M | $17M | $14M | $15M | $14M | $13M | $15M | $3M | $12M | |
| SG&A Expense | $7M | $7M | $6M | $7M | $7M | $8M | $8M | $7M | $7M | $8M | $11M | $5M | $5M | $5M | $-9M | $9M | |
| Operating Expenses | $20M | $20M | $52M | $20M | $29M | $28M | $25M | $23M | $24M | $21M | $27M | $19M | $18M | $20M | $-6M | $20M | |
| Operating Income | $-20M | $-20M | $-50M | $-19M | $-27M | $-25M | $-23M | $-23M | $-24M | $-21M | $-27M | $-19M | $-18M | $-20M | $6M | $-20M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $284.0K | · | $263.0K | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | · | $448.0K | $346.0K | $523.0K | · | $351.0K | |
| Other Non-op | $1M | $906.0K | $990.0K | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $1M | $656.0K | $786.0K | $481.0K | $619.0K | $617.0K | |
| Pretax Income | $-19M | $-20M | $-49M | $-18M | $-26M | $-23M | $-21M | $-21M | $-22M | $-20M | $-25M | $-18M | $-18M | $-20M | $6M | $-20M | |
| Income Tax | $108.0K | $95.0K | $636.0K | $0 | $1.0K | $0 | $103.0K | $-9.0K | $30.0K | $17.0K | $0 | $0 | $27.0K | $0 | $19.0K | $-23.0K | |
| Net Income | $-19M | $-20M | $-50M | $-18M | $-26M | $-23M | $-21M | $-21M | $-22M | $-20M | $-25M | $-18M | $-18M | $-20M | $6M | $-20M | |
| EPS (Basic) | $-1.07 | $-1.69 | $-5.33 | $-1.92 | $-2.74 | $-2.49 | $-2.24 | $-2.26 | $-2.43 | $-2.44 | $148.03 | $-65.08 | $-63.83 | $-72.20 | $-225.59 | $-0.55 | |
| EPS (Diluted) | $-1.07 | $-1.69 | $-5.33 | $-1.92 | $-2.74 | $-2.49 | $-2.24 | $-2.26 | $-2.43 | $-2.44 | $148.03 | $-65.08 | $-63.83 | $-72.20 | $-225.59 | $-0.55 | |
| Shares (Basic) | 17,618,441 | 11,598,717 | · | 9,391,559 | 9,390,542 | 9,384,266 | · | 9,303,218 | 8,986,545 | 8,019,626 | · | 284,156 | 276,482 | 271,522 | · | 35,247,680 | |
| Shares (Diluted) | 17,618,441 | 11,598,717 | · | 9,391,559 | 9,390,542 | 9,384,266 | · | 9,303,218 | 8,986,545 | 8,019,626 | · | 284,156 | 276,482 | 271,522 | · | 35,247,680 | |
| EBITDA | $-20M | $-20M | · | $-19M | $-27M | $-25M | · | $-23M | $-24M | $-21M | · | $-13M | $-12M | $-21M | · | $-20M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $25M | $62M | $22M | $24M | $34M | $64M | $56M | $63M | $91M | $139M | $166M | $42M | $40M | $41M | $36M | $44M | |
| Short-term Investments | $90M | $52M | $53M | $68M | $63M | $51M | $70M | $74M | $66M | · | $0 | · | · | · | $19M | · | |
| Prepaid Expense | $6M | $6M | $6M | $5M | $5M | $4M | $4M | $4M | $4M | $3M | $3M | $423.0K | $2M | $3M | $1M | $2M | |
| Current Assets | $121M | $120M | $82M | $98M | $103M | $121M | $132M | $153M | $164M | $146M | $173M | $42M | $48M | $69M | $57M | $101M | |
| PP&E (Net) | $7M | $8M | $8M | $24M | $25M | $27M | $28M | $29M | $25M | $21M | $16M | $543.0K | $1M | $2M | $10M | $3M | |
| PP&E (Gross) | $19M | $19M | $19M | $35M | $35M | $35M | $35M | $39M | $34M | $29M | $24M | $4M | $9M | $9M | $14M | $9M | |
| Accum. Depreciation | $11M | $11M | $11M | $11M | $10M | $9M | $7M | $10M | $9M | $9M | $8M | $3M | $8M | $7M | $4M | $6M | |
| Other Non-current Assets | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $3M | $2M | $3M | · | · | · | $228.0K | · | |
| Total Assets | $163M | $184M | $114M | $162M | $180M | $202M | $226M | $244M | $250M | $198M | $222M | $46M | $79M | $102M | $74M | $136M | |
| Accounts Payable | $4M | $2M | $2M | $2M | $5M | $4M | $4M | $6M | $6M | $5M | $7M | $338.0K | $1M | $3M | $3M | $4M | |
| Accrued Liabilities | $5M | $10M | $8M | $6M | $6M | $4M | $6M | $5M | $6M | $5M | $10M | $8M | $5M | $6M | $3M | $5M | |
| Current Liabilities | $13M | $15M | $12M | $15M | $17M | $13M | $15M | $14M | $12M | $11M | $19M | $10M | $8M | $22M | $9M | $20M | |
| Capital Leases | $39M | $40M | $41M | $42M | $42M | $43M | $43M | $42M | $38M | $35M | $31M | $0 | $26M | $26M | $209.0K | $27M | |
| Other Non-current Liabilities | $2M | $1M | $1M | $2M | $1M | $1M | $1M | $717.0K | $1M | $893.0K | $1M | $0 | $0 | $0 | $0 | $79.0K | |
| Total Liabilities | $60M | $64M | $62M | $63M | $65M | $63M | $66M | $64M | $52M | $47M | $52M | $10M | $34M | $48M | $9M | $54M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $12M | · | $8M | |
| Common Stock | $14.0K | $14.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $8.0K | $8.0K | $37.0K | $36.0K | $36.0K | $0 | $35.0K | |
| Paid-in Capital | $526M | $523M | $435M | $433M | $431M | $429M | $427M | $424M | $422M | $354M | $353M | $340M | $337M | $334M | $3M | $327M | |
| Retained Earnings | $-422M | $-403M | $-384M | $-334M | $-316M | $-290M | $-267M | $-245M | $-224M | $-203M | $-183M | $-304M | $-292M | $-281M | $-102M | $-244M | |
| AOCI | $-189.0K | $5.0K | $212.0K | $214.0K | $177.0K | $264.0K | $268.0K | $574.0K | $21.0K | · | $0 | $10.0K | $-6.0K | $-64.0K | $-5.0K | $-376.0K | |
| Stockholders' Equity | $103M | $120M | $51M | $99M | $115M | $139M | $160M | $180M | $198M | $151M | $170M | $37M | $45M | $53M | $-99M | $82M | |
| Liabilities + Equity | $163M | $184M | $114M | $162M | $180M | $202M | $226M | $244M | $250M | $198M | $222M | $46M | $79M | $102M | $74M | $136M | |
| Shares Outstanding | 14,705,646 | 14,422,571 | 9,417,295 | 9,397,984 | 9,390,842 | 9,388,902 | 9,377,259 | 9,318,356 | 9,279,937 | 8,022,463 | 8,016,516 | 36,926,285 | 35,963,706 | 35,751,956 | 268,468 | 35,262,233 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | · | · | · | · | · | · | · | · | · | · | · | $3M | $3M | $3M | · | $6M | |
| Restructuring | $0 | · | · | · | $1M | · | · | · | · | · | · | $0 | $359.0K | $4M | · | · | |
| Operating Cash Flow | $-17M | $-16M | $-18M | $-17M | $-19M | $-24M | $-7M | $-16M | $-15M | $-22M | $-21M | $-24M | $-20M | $-20M | $-11M | $-12M | |
| CapEx | $37.0K | $21.0K | $84.0K | $175.0K | $140.0K | $119.0K | $1M | $5M | $6M | $6M | $2M | $6M | $6M | $2M | $5M | $-16.0K | |
| Investing Cash Flow | $-18M | $-32M | $15M | $8M | $-11M | $33M | $-3M | $-13M | $-102M | $-6M | $-2M | $-12M | $7M | $15M | $4M | $13M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $-2M | · | · | |
| Stock Issued | $-3M | $83M | · | · | $0 | $0 | · | $0 | · | · | $117M | $-1.0K | $-1.0K | $1.0K | $-60.0K | $-1.0K | |
| Net Stock Activity | · | $83M | · | · | · | · | · | · | · | · | · | · | · | $1.0K | · | · | |
| Financing Cash Flow | $-3M | $88M | $380.0K | $128.0K | $5.0K | $172.0K | $932.0K | $728.0K | $68M | $139.0K | $145M | $57M | $48M | $45M | $-238.0K | $56.0K | |
| Net Change in Cash | $-38M | $40M | $-2M | $-9M | $-31M | $9M | $-9M | $-28M | $-49M | $-27M | $122M | $22M | $34M | $41M | $-7M | $1M | |
| Taxes Paid | $60.0K | $48.0K | $0 | $0 | $1.0K | $0 | $94.0K | $0 | $30.0K | $17.0K | $0 | $0 | $27.0K | $0 | · | · | |
| Free Cash Flow | · | $-16M | · | · | · | $-25M | · | · | · | $-28M | · | · | · | $-14M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | $-15M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -1764.9% | -1863.1% | -981.2% | · | · | · | · | · | · | · | -18313.4% | · | · | |
| Net Margin | · | · | · | -1657.0% | -1765.1% | -917.1% | · | · | · | · | · | · | · | -17449.1% | · | · | |
| Pretax Margin | · | · | · | -1657.0% | -1765.0% | -917.1% | · | · | · | · | · | · | · | -17427.7% | · | · | |
| EBITDA Margin | · | · | · | -1764.9% | -1863.1% | -981.2% | · | · | · | · | · | · | · | -18313.4% | · | · | |
| ROA | -11.0% | -10.2% | · | -8.9% | -12.0% | -11.7% | · | -14.5% | -13.3% | -13.1% | · | -12.7% | -9.4% | -14.7% | · | -11.6% | |
| ROE | -17.3% | -15.2% | · | -13.0% | -16.5% | -16.1% | · | -19.4% | -17.9% | -19.1% | · | -19.6% | -15.3% | -23.6% | · | -17.1% | |
| ROIC | -19.6% | -17.2% | · | -19.4% | -23.6% | -18.0% | · | -13.0% | -12.2% | -14.2% | · | -34.4% | -26.1% | -31.6% | · | -22.4% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.6 | 8.1 | · | 6.7 | 6.0 | 9.4 | · | 11.2 | 13.3 | 13.2 | · | 4.4 | 5.8 | 3.1 | · | 5.0 | |
| Quick Ratio | 9.1 | 7.7 | · | 6.3 | 5.6 | 8.9 | · | 10.1 | 12.8 | 12.6 | · | 4.3 | 4.8 | 1.9 | · | 2.2 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.2 | · | 0.1 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | · | · | -72.2 | · | -77.1 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | · | · | · | · | · | 0.0 | · | 0.0 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.02 | $8.29 | · | $10.54 | $12.26 | $14.80 | · | $19.28 | $21.34 | $18.87 | · | $0.99 | $1.26 | $1.49 | · | $2.32 | |
| Revenue / Share | $0.00 | $0.00 | · | $0.12 | $0.16 | $0.27 | · | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | $-1.39 | · | · | · | $-2.61 | · | · | · | $-2.73 | · | · | · | · | · | · | |
| Cash / Share | $1.69 | $4.28 | · | $2.57 | $3.58 | $6.83 | · | $6.78 | $9.82 | $17.30 | · | $1.13 | $1.10 | $1.14 | · | $1.24 | |
| EPS (TTM) | $-10.01 | $-11.68 | · | $-9.39 | $-9.73 | $-9.42 | · | $140.90 | $78.08 | $16.68 | · | $-426.70 | $-362.17 | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $4M | · | $7M | $6M | $5M | · | · | · | · | · | $0 | $0 | $0 | · | $0 | |
| Net Income TTM | $-107M | $-113M | · | $-88M | $-91M | $-87M | · | $-88M | $-85M | $-81M | · | $-50M | $-51M | $-54M | · | $-86M | |
| Market Cap | $194M | $163M | · | $450M | $117M | $163M | · | $311M | $314M | $722M | · | $683M | $622M | $899M | · | $3.16B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | $641M | $582M | $870M | · | $3.12B | |
| P/E | -1.3 | -1.0 | · | -5.1 | -1.3 | -1.8 | · | 0.2 | 0.4 | 5.4 | · | -0.0 | -0.0 | · | · | · | |
| P/S | 81.4 | 42.5 | · | 61.1 | 18.7 | 33.9 | · | · | · | · | · | · | · | · | · | · | |
| P/B | 1.9 | 1.4 | · | 4.5 | 1.0 | 1.2 | · | 1.7 | 1.6 | 4.8 | · | 18.6 | 13.7 | 16.9 | · | 38.5 | |
| P / Tangible Book | 1.9 | 1.4 | · | 4.5 | 1.0 | 1.2 | · | 1.7 | 1.6 | 4.8 | · | 18.6 | 13.7 | 16.9 | · | 38.5 | |
| P / Cash Flow | · | -10.2 | · | · | · | -6.7 | · | · | · | -33.0 | · | · | · | -63.6 | · | · | |
| Earnings Yield | -75.9% | -103.2% | · | -19.6% | -77.9% | -54.1% | · | 421.6% | 230.5% | 18.5% | · | -2306.5% | -2093.5% | · | · | · |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $6M | $2M | $0 | $0 | $14M |
| Betriebsgewinnmarge % | -1906.4% | -4047.1% | · | · | -597.3% |
| Nettoergebnis | $-117M | $-84M | $-81M | $-58M | $-85M |
| Verwässerte EPS | $-12.48 | $-9.37 | $-53.08 | $-227.42 | · |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | · | · | · | · | 0.0 |
| Liquiditätsgrad | 6.9 | 8.8 | 8.9 | · | 11.8 |
| Quick Ratio | 6.3 | 8.4 | 8.5 | · | 7.0 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-79M | $-78M | $-75M | · | $-79M |
Institutionelle Eigentümer (13F) 114 Einreicher · $213.2M gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
114
Gehaltener Wert
$213.2M
Neue Positionen
18
Geschlossene Positionen
11
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 18 (-15 vs. Vorquartal) | 11 (0 vs. Vorquartal) | 47 (+13 vs. Vorquartal) | 22 (-1 vs. Vorquartal) | +1.3M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Lynx1 Capital Management LP | $20.274.741 | 1.538.296 | 9,51% | Aktien |
| Qiming U.S. Ventures Management, LLC | $17.627.591 | 368.085 | 8,27% | Aktien |
| NEA Management Company, LLC | $17.106.230 | 1.297.893 | 8,02% | Aktien |
| Venrock Adviser, LLC | $13.305.210 | 1.009.500 | 6,24% | Aktien |
| Atlas Venture Life Science Advisors, LLC | $12.690.811 | 962.884 | 5,95% | Aktien |
| Balyasny Asset Management L.P. | $12.544.500 | 951.783 | 5,88% | Aktien |
| BlackRock, Inc. | $10.776.245 | 817.621 | 5,05% | Aktien |
| Affinity Asset Advisors, LLC | $9.316.995 | 706.904 | 4,37% | Aktien |
| Nantahala Capital Management, LLC | $8.699.274 | 660.036 | 4,08% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $7.129.958 | 540.968 | 3,34% | Aktien |
| ADAR1 Capital Management, LLC | $7.117.912 | 540.054 | 3,34% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $5.993.974 | 454.778 | 2,81% | Aktien |
| Driehaus Capital Management LLC | $5.931.593 | 450.045 | 2,78% | Aktien |
| TCG Crossover Management, LLC | $5.486.847 | 416.301 | 2,57% | Aktien |
| Kalehua Capital Management LLC | $5.338.427 | 405.040 | 2,50% | Aktien |
| Siren, L.L.C. | $4.582.923 | 347.718 | 2,15% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $3.940.478 | 298.974 | 1,85% | Aktien |
| VANGUARD GROUP INC | $3.922.009 | 489.639 | 1,84% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $3.913.148 | 296.870 | 1,84% | Aktien |
| 72 Investment Holdings, LLC | $3.648.633 | 276.831 | 1,71% | Aktien |
| STATE STREET CORP | $3.065.497 | 232.587 | 1,44% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.946.402 | 223.551 | 1,38% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $2.346.976 | 178.071 | 1,10% | Aktien |
| JPMORGAN CHASE & CO | $1.645.760 | 124.726 | 0,77% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $1.560.960 | 118.434 | 0,73% | Aktien |
| GOLDMAN SACHS GROUP INC | $1.541.836 | 116.983 | 0,72% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $1.456.706 | 110.524 | 0,68% | Aktien |
| UBS Group AG | $1.389.871 | 105.453 | 0,65% | Aktien |
| NORTHERN TRUST CORP | $1.161.013 | 88.089 | 0,54% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $987.195 | 74.901 | 0,46% | Aktien |
| CITADEL ADVISORS LLC | $935.780 | 71.000 | 0,44% | Kaufoption |
| F/m Investments LLC | $837.747 | 63.562 | 0,39% | Aktien |
| EMERALD MUTUAL FUND ADVISERS TRUST | $837.747 | 63.562 | 0,39% | Aktien |
| Walleye Capital LLC | $715.529 | 54.289 | 0,34% | Aktien |
| Quantinno Capital Management LP | $694.850 | 52.720 | 0,33% | Aktien |
| BANK OF AMERICA CORP /DE/ | $681.498 | 51.707 | 0,32% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $644.765 | 48.920 | 0,30% | Aktien |
| XTX Topco Ltd | $630.254 | 47.819 | 0,30% | Aktien |
| CITADEL ADVISORS LLC | $532.340 | 40.390 | 0,25% | Aktien |
| FMR LLC | $513.691 | 38.975 | 0,24% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $472.543 | 35.853 | 0,22% | Aktien |
| D. E. Shaw & Co., Inc. | $450.927 | 34.213 | 0,21% | Aktien |
| Jump Financial, LLC | $446.881 | 33.906 | 0,21% | Aktien |
| Bank of New York Mellon Corp | $418.196 | 31.730 | 0,20% | Aktien |
| AIHC Capital Management Ltd | $398.893 | 30.265 | 0,19% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $383.538 | 29.100 | 0,18% | Kaufoption |
| Mariner, LLC | $367.824 | 27.908 | 0,17% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $346.028 | 26.254 | 0,16% | Aktien |
| PANAGORA ASSET MANAGEMENT INC | $337.039 | 25.572 | 0,16% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $317.770 | 24.110 | 0,15% | Aktien |
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Atlas Venture Fund XI, L.P., Atlas Venture Associates XI, L.P., Atlas Venture Associates XI, LLC, Atlas Venture Opportunity Fund II, L.P., Atlas Venture Associates Opportunity II, L.P., Atlas Venture Associates Opportunity II, LLC ×2 Einreichungen | 4. August 2026 | 4,90% | Änderung | · | SEC |
| New Enterprise Associates 17, L.P., NEA Partners 17, L.P., NEA 17 GP, LLC, Forest Baskett, Ali Behbahani, Carmen Chang, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Edward T. Mathers, Scott D. Sandell, Paul Walker, Rick Yang ×3 Einreichungen | 12. März 2026 | 9,90% | Änderung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 40 Insider · 15 Führungskräfte · 13 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Vineet Agarwal | Chief Financial Officer | 3. Februar 2025 A | 0 | 0 | 0 | $0 |
| Peter P. Pfreundschuh | Chief Financial Officer | 22. Februar 2022 S | 8.927 | 0 | 0 | $0 |
| Todd Chappell | Chief Operating Officer | 15. Juli 2026 A | 24.464 | 0 | 1 | $-34.309 |
| Oliver Dolan | Senior Vice President, Finance | 11. September 2026 S | 16.241 | 0 | 4 | $-136.047 |
| Loic A Vincent | Chief Scientific Officer | 15. Juli 2026 A | 25.797 | 0 | 1 | $-37.017 |
| Jeffrey Cerio | General Counsel | 15. Juli 2026 A | 41.793 | 0 | 1 | $-71.575 |
| Olukemi Olugemo | Chief Medical Officer | 3. Februar 2025 A | · | 0 | 0 | $0 |
| Shelby J. Walker | Senior Vice President, General Counsel and Secretary | 3. November 2023 A | · | 0 | 0 | $0 |
| Steve Colletti | Chief Scientific Officer | 3. November 2023 A | · | 0 | 0 | $0 |
| Richard J. Mitrano | VP Finance & Operations | 21. August 2023 S | 48.457 | 0 | 0 | $0 |
| Christopher R. Loose | Chief Scientific Officer | 28. Juli 2023 S | 183.650 | 0 | 0 | $0 |
| Quentin Mccubbin | Chief Manufacturing Officer | 26. Januar 2023 A | 38.340 | 0 | 0 | $0 |
| Wendy S Arnold | Chief People Officer | 26. Januar 2023 A | 21.186 | 0 | 0 | $0 |
| Carl Lebel | Chief Development Officer | 26. Januar 2023 A | 26.343 | 0 | 0 | $0 |
| Michael Bookman | General Counsel and Secretary | 20. April 2021 A | · | 0 | 0 | $0 |
| FORMELA JEAN FRANCOIS | Direktor | 14. September 2026 S | 132.650 | 0 | 24 | $-5.160.282 |
| Rachel Meyers | Direktor | 10. Juni 2026 A | · | 0 | 0 | $0 |
| Katharine Knobil | Direktor | 10. Juni 2026 A | · | 0 | 0 | $0 |
| Ali Behbahani | Direktor | 10. Juni 2026 A | 1.297.893 | 0 | 0 | $0 |
| Timothy R Pearson | Direktor | 10. Juni 2026 A | · | 0 | 0 | $0 |
| Nessan Bermingham | Direktor | 10. Juni 2026 A | 35.114 | 0 | 0 | $0 |
| David L. Lucchino | Direktor | 11. Juni 2024 A | 22.150 | 0 | 0 | $0 |
| Michael Huang | Direktor | 17. August 2022 D | · | 0 | 0 | $0 |
| Cynthia L Feldmann | Direktor | 17. August 2022 D | · | 0 | 0 | $0 |
| Robert Langer | Direktor | 17. August 2022 D | 214.326 | 0 | 0 | $0 |
| Joel S Marcus | Direktor | 17. August 2022 D | 307.116 | 0 | 0 | $0 |
| BARBERICH TIMOTHY J | Direktor | 17. August 2022 D | 80.650 | 0 | 0 | $0 |
| Marc A Cohen | Direktor | 21. Juni 2022 A | 605.820 | 0 | 0 | $0 |
| Rick Yang | 10%-Eigentümer | 10. März 2026 P | 1.297.893 | 2 | 0 | $5.000.000 |
| Carmen Chang | 10%-Eigentümer | 10. März 2026 P | 1.297.893 | 2 | 0 | $5.000.000 |
| Mohamad Makhzoumi | 10%-Eigentümer | 10. März 2026 P | 1.297.893 | 2 | 0 | $5.000.000 |
| Anthony A. Florence, Jr. | 10%-Eigentümer | 10. März 2026 P | 1.297.893 | 2 | 0 | $5.000.000 |
| Paul Walker | 10%-Eigentümer | 10. März 2026 P | 1.297.893 | 2 | 0 | $5.000.000 |
| Edward T. Mathers | 10%-Eigentümer | 10. März 2026 P | 1.297.893 | 2 | 0 | $5.000.000 |
| Forest Baskett | 10%-Eigentümer | 10. März 2026 P | 1.297.893 | 2 | 0 | $5.000.000 |
| Scott D. Sandell | 10%-Eigentümer | 10. März 2026 P | 1.297.893 | 2 | 0 | $5.000.000 |
| Alexandria Venture Investments, LLC | 10%-Eigentümer | 7. Oktober 2019 C | 956.175 | 0 | 0 | $0 |
| William J. Mclean | 10%-Eigentümer | 2. Oktober 2019 A | · | 0 | 0 | $0 |
| Ram Aiyar | · | 4. August 2026 S | 69.046 | 0 | 2 | $-259.567 |
| Dana Charles Hilt | · | 20. April 2021 A | · | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 15 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IWC · iShares Trust | 0,03% | 38.277 SH | 11. September 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 7.950 SH | 19. August 2026 | Täglich |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,01% | 2.113 SH | 2. Oktober 2026 | Täglich |
| IWO · iShares Trust | 0,01% | 58.538 SH | 11. September 2026 | Täglich |
| IWM · iShares Trust | 0,00% | 281.853 SH | 11. September 2026 | Täglich |
| RSSL · Global X Funds | 0,00% | 5.318 NS | 31. Juli 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 9.978 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 3.332 SH | 3. September 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 135.396 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 311.262 SH | 19. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 63.717 SH | 19. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2.170 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 428 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,00% | 28.271 SH | 19. August 2026 | Täglich |
| IWN · iShares Trust | · | 82.104 SH | 11. September 2026 | Täglich |
KRRO Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 18 Analysten
KAUF
Median-Ziel
$21.50
+123,0%
5 27,8%
Starker Kauf
11 61,1%
Kauf
2 11,1%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
10 Analysten · 2026-09-30Mittelwert-Ziel $20.20 +109,5%
← Unter allen Zielen
Aktueller Preis $9.64
Tief$10.00
Mittelwert$20.20
Hoch$30.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| KRRO | $75M | -0.6 | 181.5% | -1834.5% | -140.8% | · |
| NERV | $174M | -0.1 | · | · | 339.5% | · |
| TNXP | $200M | -1.1 | 29.8% | -946.2% | -60.0% | · |
| ABOS | $128M | -1.1 | · | · | -129.4% | · |
| HUMA | · | · | · | · | · | · |
| PMVP | $67M | -0.8 | -40.5% | -1226.8% | -63.4% | · |
| OTLK | $57M | -0.6 | · | -4416.2% | 193.1% | 4.0% |
| RNA | $10.91B | -14.5 | 72.1% | -3650.4% | -47.5% | · |
| CBUS | · | -0.6 | -14.6% | -3492.3% | -223.0% | · |
| CRBU | $151M | -1.0 | 11.7% | -1327.4% | -102.8% | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 6, 2026